ADVFN - Advanced Financial Network.
HOME» NYSE » N » NVS Stock Price » NVS Stock News

Novartis Share News

 Novartis Ag Basel Stock Price
NVS Stock Price
 Novartis Ag Basel Stock Chart
NVS Stock Chart
 Novartis Ag Basel Stock News
NVS Stock News
 Novartis Ag Basel Company Information
NVS Company Information
 Novartis Ag Basel Stock Trades
NVS Stock Trades

WSJ BLOG/Health: A.M. Vitals: Texas Board to Vote on Stem-Cell Rules

(This story has been posted on The Wall Street Journal Online's Health Blog at http://blogs.wsj.com/health.) By Mark Long Here's what's making health news this morning: Texas Eyes Change in Stem-Cell Rules (WSJ): The state's medical board will vote today on rules that would make it easier for physicians to offer treatments using adult stem cells. Bayer Said to Pay $110 Million in Yaz Birth-Control Cases (Bloomberg News): People familiar with the agreements told Bloomberg that the German drug maker will settle about 500 lawsuits claiming the pills caused blood clots. States Seek Curb on Patient Bills for Costly Drugs (New York Times): Lawmakers in at least 20 states have introduced bills to limit the amount patients with diseases that are expensive to treat have to pay out of pocket. Medicare to Settle Hospital Reimbursement Dispute (Los Angeles Times): The Centers for Medicare and Medical Services agreed to settle the dispute with about 2,200 hospitals over an error in reimbursement rates. Sexual Side Effects Added to Merck Drug Labels (Reuters): U.S. health regulators said the labels for a baldness treatment, Propecia, and one for enlarged prostate, Proscar, will note side effects that lasted after use of the drugs ended. Hospitals Drop Plan for Merger (WSJ): St. Anthony Medical Center and Rockford Memorial Hospital in Rockford, Ill., bowed to pressure from the FTC, which said a deal would make a local monopoly. Novartis: MS Pill Gilenya Patient Develops Rare Brain Disease (Dow Jones Newswires): The multiple-sclerosis patient, diagnosed with often-fatal progressive multifocal leukoencephalopathy, had also been previously treated with another MS drug, Novartis said. -For continuously updated news from The Wall Street Journal, see WSJ.com at http://wsj.com.

Stock News for Novartis (NVS)
DateTimeHeadline
03/30/201508:42:35Novartis teams up with Aduro Biotech in cancer immunotherapy
03/28/201515:03:023 Top Stocks for Obamacare Lovers
03/28/201513:08:023 Little-Known Biotechs Working On Potential Blockbusters
03/28/201512:03:025 Freakishly Expensive Cancer Drugs
03/25/201509:03:02Is It Time for GlaxoSmithKline plc to Change Management?
03/24/201508:11:01Is This The Biggest Threat to Isis Pharmaceuticals Stock?
03/23/201517:44:29This Market Could Grow 6250% in 10 Years
03/23/201510:14:03This Market Could Grow 6250% in 10 Years
03/21/201512:04:06Dividend Stocks: 2 to Avoid, 1 to Buy
03/20/201507:56:19Court rejects Amgen's bid to block Neupogen biosimilar
03/20/201507:52:39How ARM's Edward Lanphier Is Fighting For Cell Therapy Cures...
03/19/201518:46:14Judge Denies Amgen's Request to Block Novartis's Biosimilar of...
03/18/201519:18:18How The Rushed Biosimilar Law Is Yielding Go-Slow Launches
03/18/201507:45:27AstraZeneca combo lung disease drug successful in Phase 3 studies
03/17/201517:24:32ADR Shares End Mixed; BHP Billiton Shares Rise
03/17/201507:35:19New indication for Novartis bone marrow disorder drug cleared...
03/17/201504:45:54Novartis Gets EU Approval for Jakavi Rare Blood Cancer Drug
03/13/201515:51:14Oxford Biomedica Hails Novartis Contract, Narrows Loss
03/13/201506:30:41Wall Street Breakfast: Japan Marches Higher As Nikkei Breaches...
03/12/201516:33:14GSK Plans Partial Stake Sale in Aspen Pharmacare

Novartis and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad